NASDAQ:NMTC NeuroOne Medical Technologies (NMTC) Stock Price, News & Analysis $1.05 +0.01 (+0.95%) As of 01/17/2025 04:00 PM Eastern Add Compare Share Share Stock Analysis Stock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends About NeuroOne Medical Technologies Stock (NASDAQ:NMTC) 30 days 90 days 365 days Advanced Chart View Price History Chart DataSkip Price History Chart Get NMTC alerts:Sign Up Key Stats Today's Range$1.00▼$1.0950-Day Range$0.59▼$1.1452-Week Range$0.55▼$1.59Volume189,775 shsAverage Volume208,574 shsMarket Capitalization$32.38 millionP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingN/A Company OverviewNeuroOne Medical Technologies Corporation, a developmental stage company, provides solutions for EEG recording, brain stimulation and ablation solutions for patients suffering from epilepsy, Parkinson's disease, dystonia, essential tremors, and chronic pain due to failed back surgeries and other related neurological disorders. It also fucuses on applications for other areas, such as depression, mood disorders, pain, incontinence, high blood pressure, and artificial intelligence. It has a strategic partnership with RBC Medical Innovations to develop a radio frequency ablation generator. The company was incorporated in 2009 and is based in Eden Prairie, Minnesota.Read More… NeuroOne Medical Technologies Stock Analysis - MarketRank™See Top Rated MarketRank™ Stocks10th Percentile Overall ScoreNMTC MarketRank™: NeuroOne Medical Technologies scored higher than 10% of companies evaluated by MarketBeat, and ranked 917th out of 944 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's OpinionN/AAnalyst RatingN/A Consensus RatingThere is not enough analysis data for NeuroOne Medical Technologies. Earnings and Valuation0.0 / 5Proj. Earnings GrowthN/A Price to Earnings Ratio vs. the MarketThe P/E ratio of NeuroOne Medical Technologies is -2.28, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of NeuroOne Medical Technologies is -2.28, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioNeuroOne Medical Technologies has a P/B Ratio of 35.00. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.Read more about NeuroOne Medical Technologies' valuation and earnings. Short Interest5.0 / 5Short Interest LevelHealthy Percentage of Shares Shorted0.26% of the float of NeuroOne Medical Technologies has been sold short.Short Interest Ratio / Days to CoverNeuroOne Medical Technologies has a short interest ratio ("days to cover") of 0.4, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in NeuroOne Medical Technologies has recently decreased by 37.12%, indicating that investor sentiment is improving significantly. Dividend0.0 / 5Dividend StrengthN/A Dividend YieldNeuroOne Medical Technologies does not currently pay a dividend.Dividend GrowthNeuroOne Medical Technologies does not have a long track record of dividend growth. Sustainability and ESGN/AEnvironmental ScoreN/A Percentage of Shares Shorted0.26% of the float of NeuroOne Medical Technologies has been sold short.Short Interest Ratio / Days to CoverNeuroOne Medical Technologies has a short interest ratio ("days to cover") of 0.4, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in NeuroOne Medical Technologies has recently decreased by 37.12%, indicating that investor sentiment is improving significantly. News and Social Media1.4 / 5News SentimentN/A News SentimentNeuroOne Medical Technologies has a news sentiment score of 0.50. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This news sentiment score is similar to the average news sentiment of Medical companies. Company Ownership0.0 / 5Insider TradingN/A Insider Buying vs. Insider SellingIn the past three months, NeuroOne Medical Technologies insiders have not sold or bought any company stock.Percentage Held by InsidersOnly 7.50% of the stock of NeuroOne Medical Technologies is held by insiders.Percentage Held by InstitutionsOnly 16.07% of the stock of NeuroOne Medical Technologies is held by institutions.Read more about NeuroOne Medical Technologies' insider trading history. Receive NMTC Stock News and Ratings via Email Sign-up to receive the latest news and ratings for NeuroOne Medical Technologies and its competitors with MarketBeat's FREE daily newsletter. Email Address NMTC Stock News HeadlinesNeuroOne Medical Technologies Faces Delisting from Nasdaq Due to Non-ComplianceJanuary 13, 2025 | americanbankingnews.comNeuroOne Medical Technologies (NASDAQ: NMTC) Releases Preliminary Financial Results and Corporate PresentationJanuary 12, 2025 | americanbankingnews.comDonald Trump is about to free crypto from its chains …With Donald Trump’s return to the oval office, the war on crypto is over. The digital currency is not only set to be released from its constraints … it could be about to explode. Trump has vowed to roll back Biden’s “crusade against crypto” on his first day in office.January 20, 2025 | Weiss Ratings (Ad)NeuroOne Announces Preliminary Q1 Fiscal 2025 Revenue Of $6.2 MlnJanuary 10, 2025 | markets.businessinsider.comNeuroOne® Announces Preliminary Unaudited First Quarter Fiscal 2025 Revenue Increase to a Record $6.2 MillionJanuary 10, 2025 | globenewswire.comNeuroOne® Announces Virtual Investor Webinar on January 9, 2025 at 11:00 a.m. ESTJanuary 3, 2025 | globenewswire.comNeuroOne Medical Technologies Corporation (NASDAQ:NMTC) Q4 2024 Earnings Call TranscriptDecember 19, 2024 | msn.comNeuroOne Medical Technologies Corporation (NMTC) Q4 2024 Earnings Call TranscriptDecember 17, 2024 | seekingalpha.comSee More Headlines NMTC Stock Analysis - Frequently Asked Questions How have NMTC shares performed this year? NeuroOne Medical Technologies' stock was trading at $0.8259 at the beginning of 2025. Since then, NMTC stock has increased by 27.1% and is now trading at $1.05. View the best growth stocks for 2025 here. How were NeuroOne Medical Technologies' earnings last quarter? NeuroOne Medical Technologies Co. (NASDAQ:NMTC) posted its quarterly earnings results on Tuesday, December, 17th. The company reported ($0.11) EPS for the quarter. NeuroOne Medical Technologies had a negative trailing twelve-month return on equity of 407.04% and a negative net margin of 356.76%. How do I buy shares of NeuroOne Medical Technologies? Shares of NMTC stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of NeuroOne Medical Technologies own? Based on aggregate information from My MarketBeat watchlists, some other companies that NeuroOne Medical Technologies investors own include Schwab US Large-Cap ETF (SCHX), NVIDIA (NVDA), Advanced Micro Devices (AMD), NIO (NIO), Ford Motor (F), Meta Platforms (META) and Plug Power (PLUG). Company Calendar Last Earnings12/17/2024Today1/20/2025Next Earnings (Estimated)2/11/2025Fiscal Year End9/30/2025Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Surgical & medical instruments Sub-IndustryMedical Equipment Current SymbolNASDAQ:NMTC CUSIPN/A CIK1500198 Webwww.originalsourcemusic.com Phone(952) 426-1383FaxN/AEmployees20Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)($0.46) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-12,320,000.00 Net Margins-356.76% Pretax Margin-356.73% Return on Equity-407.04% Return on Assets-229.19% Debt Debt-to-Equity RatioN/A Current Ratio2.09 Quick Ratio0.90 Sales & Book Value Annual Sales$3.45 million Price / Sales9.39 Cash FlowN/A Price / Cash FlowN/A Book Value$0.03 per share Price / Book35.00Miscellaneous Outstanding Shares30,840,000Free Float28,529,000Market Cap$32.38 million OptionableOptionable Beta0.41 Unlock the Potential in Options TradingOptions trading isn’t just for the Wall Street elite; it’s an accessible strategy for anyone armed with the proper knowledge. Think of options as a strategic toolkit, with each tool designed for a specific financial task. Keep reading to learn how options trading can help you use the market’s volatility to your advantage.Get This Free Report This page (NASDAQ:NMTC) was last updated on 1/20/2025 by MarketBeat.com Staff From Our PartnersLast time you’ll see this priced at $1.00When was the last time you bought something for a buck? I don’t even think you can buy anything at McDonalds f...StocksToTrade | SponsoredMust-See: 5-Second Trump PredictionPresident Trump's prediction is about to become a reality... Opening a rare window of opportunity for you t...InvestorPlace | SponsoredBill Gates’ is about to mint millionaires (again) with Stargate.This little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredJanuary 29th - the next big trading catalyst to watch Mark your calendar for January 29th. Because on that day, I believe we could see a $2 Trillion shock INTO t...Timothy Sykes | SponsoredWarren Buffett Bets $40 Billion—You Can Get in for $20I call it "The Last Retirement Stock You'll Ever Need." Warren Buffett himself owns $40 billion of stock in...Behind the Markets | SponsoredKamala’s final humiliation The investments connected to Trump's second term in ways that almost nobody outside his inner circle is aware ...Porter & Company | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding NeuroOne Medical Technologies Co. Please log in to your account or sign up in order to add this asset to your watchlist. Share NeuroOne Medical Technologies With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.